The company's latest presentation supports the idea that its lead program will make billions.With a gain of more than 531% over the last 12 months, shares of Viking Therapeutics (VKTX 1.44%) are a hot commodity, to say the least. And as of early November, there's one more big green flag suggesting that investors who take the plunge will be wealthier than before. Even an investment on the scale of $5,000 could see a meaningful run-up, assuming its plans to compete in the market for anti-obesity medicines com ...